Analyst Ratings for Lakefront Biotherapeutics (LKFT)
LKFT Rating Summary
LKFT Price Target Summary
- Highest: $45.00 (RBC Capital)
- Lowest: $26.00 (Morgan Stanley)
- Average: $35.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$35.50 (+18.7%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 70%
Avg. $ Target:
$35.50 (+18.7%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 70%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/23/2026 | RBC Capital | Brian Abrahams | Upgrade | Outperform (Sector Perform) |
45.00 (26.00) |
29.59 (29.90) |
1.05% | Details |
| 8/21/2026 | TD Cowen | Phil Nadeau | New Coverage | Buy (N/A) |
N/A (N/A) |
28.27 (29.90) |
5.77% | Details |
 |
||||||||
